|
RXRB expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.055700E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.355400E-01 |
| Normal-vs-Stage2 |
1.136380E-01 |
| Normal-vs-Stage3 |
7.143800E-03 |
| Normal-vs-Stage4 |
6.958700E-03 |
| Stage1-vs-Stage2 |
1.386370E-01 |
| Stage1-vs-Stage3 |
1.100010E-02 |
| Stage1-vs-Stage4 |
1.070030E-02 |
| Stage2-vs-Stage3 |
7.100400E-01 |
| Stage2-vs-Stage4 |
5.442200E-01 |
| Stage3-vs-Stage4 |
7.449600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.361610E-02 |
| Normal-vs-AfricanAmerican |
3.965800E-01 |
| Normal-vs-Asian |
1.558020E-02 |
| Caucasian-vs-AfricanAmerican |
1.719600E-02 |
| Caucasian-vs-Asian |
3.749600E-02 |
| AfricanAmerican-vs-Asian |
3.201600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.597900E-03 |
| Normal-vs-Female |
8.665800E-01 |
| Male-vs-Female |
1.919480E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.660200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.924000E-01 |
| Normal-vs-Age(61-80Yrs) |
2.268000E-02 |
| Normal-vs-Age(81-100Yrs) |
2.241400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.609600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.074400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.042800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.434980E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.709400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.075000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.220000E-04 |
| Normal-vs-Grade 2 |
8.497000E-01 |
| Normal-vs-Grade 3 |
5.139000E-03 |
| Normal-vs-Grade 4 |
6.48279999999612E-05 |
| Grade 1-vs-Grade 2 |
2.012000E-04 |
| Grade 1-vs-Grade 3 |
2.1170999997544E-07 |
| Grade 1-vs-Grade 4 |
2.56679999477427E-08 |
| Grade 2-vs-Grade 3 |
1.008040E-02 |
| Grade 2-vs-Grade 4 |
2.844000E-04 |
| Grade 3-vs-Grade 4 |
4.590300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.844600E-01 |
| Normal-vs-ccB subtype |
9.60100000000352E-05 |
| ccA subtype-vs-ccB subtype |
4.36979999995923E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.346200E-01 |
| Normal-vs-N1 |
1.323680E-02 |
| N0-vs-N1 |
6.185600E-02 |
|
|
